Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children

Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children

Bibliographic Details
Main Authors:	Corinne Levy, Naim Ouldali, Emmanuelle Varon, Stéphane Béchet, Stéphane Bonacorsi, Robert Cohen
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2021-08-01
Series:	Emerging Infectious Diseases
Subjects:	pneumoccocal serotypes children PCVs pneumococcal conjugate vaccines Streptococcus pneumoniae vaccines
Online Access:	https://wwwnc.cdc.gov/eid/article/27/8/21-0037_article

Similar Items

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
by: Oluwaseun Rume-Abiola Oyewole, et al.
Published: (2021-05-01)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
by: Catarina Silva-Costa, et al.
Published: (2018-07-01)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
by: Murat Sütçü, et al.
Published: (2017-02-01)

Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
by: John Njuma Libwea, et al.
Published: (2020-09-01)

Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era
by: Chih-Ho Chen, et al.
Published: (2020-12-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine
by: Idrissa Diawara, et al.
Published: (2017-04-01)

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea
by: Eun Hwa Choi, et al.
Published: (2011-04-01)

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
by: Angel Vila-Corcoles, et al.
Published: (2018-04-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia
by: David Felipe Severiche-Bueno, et al.
Published: (2021-04-01)

Pneumococcal Disease Prevention: Are We on the Right Track?
by: Nicola Principi, et al.
Published: (2021-03-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Nasopharyngeal Pneumococcal Colonization among Children after Pneumococcal Conjugate Vaccine Introduction
by: Manoochehr Karami, et al.
Published: (2017-08-01)

Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
by: Juan Buades, et al.
Published: (2021-01-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine Booster in Taiwanese Toddlers
by: Pei-Lan Shao, et al.
Published: (2006-01-01)

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines
by: Oana Falup-Pecurariu
Published: (2012-12-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010–2017
by: Kimiko Ubukata, et al.
Published: (2018-11-01)

Global Coverage of Pneumococcal Conjugate Vaccine (PCV) and Serotype Distribution after Receiving Vaccine among Targeted PCV Vaccine Countries: A Systematic Review
by: S Rahmani, et al.
Published: (2020-06-01)

Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine
by: Chinelo Ebruke, et al.
Published: (2015-04-01)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
by: Sandra S. Richter, et al.
Published: (2013-07-01)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
by: Earnshaw Stephanie R, et al.
Published: (2012-04-01)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Mirjam J. Knol, et al.
Published: (2015-11-01)

Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
by: Giske Biesbroek, et al.
Published: (2014-02-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
by: Ahmet Arvas, et al.
Published: (2017-08-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Nasopharyngeal carriage of Streptococcus pneumoniae in Romanian children before the introduction of the pneumococcal conjugated vaccination into the national immunization programme: a national, multi-centre, cross-sectional observational study
by: Monica Luminos, et al.
Published: (2014-12-01)

Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
by: Deirdre A. Collins, et al.
Published: (2017-09-01)

Molecular investigation on the impact of the pneumococcal polysaccharide-protein conjugates vaccine (PCV) on bacterial nasopharyngeal colonization in children
by: Olwagen, Courtney Paige
Published: (2017)

Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012-2014) despite continued reductions in other 13-valent conjugate vaccine serotypes.
by: Andreia N Horácio, et al.
Published: (2016-10-01)

Strain Level Streptococcus Colonization Patterns during the First Year of Life
by: Meredith S. Wright, et al.
Published: (2017-09-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)

Epidemiology Characteristics of Streptococcus pneumoniae From Children With Pneumonia in Shanghai: A Retrospective Study
by: Wantong Zhao, et al.
Published: (2019-07-01)

Efficacy of 13-valent pneumococcal conjugate vaccine in healthcare workers
by: L A Shpagina, et al.
Published: (2018-11-01)

Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study
by: Claire von Mollendorf, et al.
Published: (2021-09-01)

Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco
by: Idrissa Diawara, et al.
Published: (2015-11-01)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
by: Ashley Makwana, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_43c9htosgl1130r7pv1qjkgnps